The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Features of HPV+ OPSCC predictive of recurrence identified by transcriptional profiling of a case-control cohort.
 
Devraj Basu
No Relationships to Disclose
 
Malay Kumar Sannigrahi
No Relationships to Disclose
 
Lovely Raghav
No Relationships to Disclose
 
Lova Sun
Consulting or Advisory Role - Bayer; Genmab/Seagen; Genzyme; MJH Life Sciences; Regeneron
Research Funding - Abbvie (Inst); Blueprint Medicines (Inst); Erasca, Inc (Inst); Immunocore (Inst); IO Biotech (Inst); Seagen (Inst)
 
Roger B. Cohen
Consulting or Advisory Role - Actuate Therapeutics; Coherus Biosciences; Fstar Therapeutics; Ono Pharmaceutical
Research Funding - AstraZeneca (Inst); F-Star Biotechnology (Inst); Innate Pharma (Inst); Macrogenics (Inst); Xencor (Inst)
 
Phyllis A. Gimotty
Patents, Royalties, Other Intellectual Property - Coukos G, Buckanovich R, Gimotty PA: Tumor vasculature markers and methods of use thereof. European Patent Office EP1987160A2; Coukos G, Buckanovich R, Gimotty PA: Tumor vasculature markers and methods of use thereof. United States Patent Number 11/657,719, 2007.
 
Jalal Jalaly
No Relationships to Disclose
 
Alexander T. Pearson
Honoraria - Caris Life Sciences
Consulting or Advisory Role - Abbvie; Ayala Pharmaceuticals; Elevar Therapeutics; Prelude Therapeutics
Research Funding - Abbvie (Inst); EMD Serono (Inst); Kura Oncology (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences